1) To understand the histopathologic basis of late gadolinium enhancement in HCM and how best to measure it. 2) To appreciate the added value of late gadolinium enhancement in prognostication in HCM. 3) To learn about several under-appreciated phenotypic signs of HCM that may be present even in so-called Œgene-positive phenotype-negative¹ HCM.
This session is part of Canada Presents at RSNA 2014.
Crean, A,
Refining the Phenotype of Genetic Hypertrophic Cardiomyopathy with Cardiac MRI. Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL.
http://archive.rsna.org/2014/14002196.html